BMRN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 55.705 USD 0.3%

Market Cap: $10.8B

	Biomarin Pharmaceutical Inc NASDAQ:BMRN	US
	Hongkong and Shanghai Hotels Ltd HKEX:45	HK
P	Pakuwon Jati Tbk PT IDX:PWON	ID
	Hyatt Hotels Corp NYSE:H	US
	Empower Clinics Inc OTC:EPWCF	CA
D	Dollarama Inc XBER:DR3	CA
	Liberty Broadband Corp NASDAQ:LBRDA	US
	Elis SA PAR:ELIS	FR
	COSCIENS Biopharma Inc TSX:CSCI	CA
	Equitable Group Inc TSX:EQB	CA

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

77% > 80%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

3% > 10%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

3% > 8%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.